1. Single Crystal, DFT and Docking Studies of a Benzimidazolium Salt
   S. Akkoç et al, 2020, Crystallography Reports CrossRef
2. Vildagliptin prevents cognitive deficits and neuronal apoptosis in a rat model of Alzheimer's disease
   Qing‑Hua Ma et al, 2017, Molecular Medicine Reports CrossRef
3. Recent Studies on Design and Development of Drugs Against Alzheimer’s Disease (AD) Based on Inhibition of BACE-1 and Other AD-causative Agents
   Satya P. Gupta et al, 2020, Current Topics in Medicinal Chemistry CrossRef
4. Identification and profiling of 3,5-dimethyl-isoxazole-4-carboxylic acid [2-methyl-4-((2S,3′S)-2-methyl-[1,3′]bipyrrolidinyl-1′-yl)phenyl] amide as histamine H3 receptor antagonist for the treatment of depression
   Zhongli Gao et al, 2013, Bioorganic & Medicinal Chemistry Letters CrossRef
5. Procognitive Properties of Drugs with Single and Multitargeting H3 Receptor Antagonist Activities
   Katarina Nikolic et al, 2014, CNS Neuroscience & Therapeutics CrossRef
6. Histamine H3 Inverse Agonist BF 2649 or Antagonist with Partial H4 Agonist Activity Clobenpropit Reduces Amyloid Beta Peptide-Induced Brain Pathology in Alzheimer’s Disease
   Ranjana Patnaik et al, 2018, Molecular Neurobiology CrossRef
7. Pharmacophore-based virtual screening of ZINC database, molecular modeling and designing new derivatives as potential HDAC6 inhibitors
   Priya Poonia et al, 2023, Molecular Diversity CrossRef
8. Discovery of a potent, selective, and orally bioavailable histamine H3 receptor antagonist SAR110068 for the treatment of sleep–wake disorders
   Zhongli Gao et al, 2013, Bioorganic & Medicinal Chemistry Letters CrossRef
9. Structure-guided pharmacophore based virtual screening, docking, and molecular dynamics to discover repurposed drugs as novel inhibitors against endoribonuclease Nsp15 of SARS-CoV-2
   Prakash Jha et al, 2022, Journal of Biomolecular Structure and Dynamics CrossRef
10. Discovery of novel dual acetylcholinesterase and butyrylcholinesterase inhibitors using machine learning and structure-based drug design
    Manish Kumar Tripathi et al, 2023, Journal of Molecular Structure CrossRef
11. New developments around histamine H3receptor antagonists/inverse agonists: a patent review (2010 – present)
    Dorota Łażewska et al, 2014, Expert Opinion on Therapeutic Patents CrossRef
12. Neuronal histamine and cognitive symptoms in Alzheimer's disease
    Armin Zlomuzica et al, 2016, Neuropharmacology CrossRef
13. Integration of ligand and structure-based pharmacophore screening for the identification of novel natural leads against Euchromatic histone lysine methyltransferase 2 (EHMT2/G9a)
    Abhisek Jana et al, 2024, Journal of Biomolecular Structure and Dynamics CrossRef
14. Beware of docking!
    Yu-Chian Chen, 2015, Trends in Pharmacological Sciences CrossRef
15. Therapeutics of Neurotransmitters in Alzheimer’s Disease
    Ramesh Kandimalla et al, 2017, Journal of Alzheimer's Disease CrossRef
16. Methodologies Related to Computational Models in View of Developing Anti-Alzheimer Drugs: An Overview
    Kirtee Baheti et al, 2019, Current Drug Discovery Technologies CrossRef
17. In silico and in vitro studies of two non‐imidazole multiple targeting agents at histamine H3 receptors and cholinesterase enzymes
    Nakisa Ghamari et al, 2020, Chemical Biology & Drug Design CrossRef